You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Busulfan

Showing 51 - 75 of 765
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Polymorphisms and Busulfan Pharmacokinetic Study

Recruiting
  • Children Who Receive a Stem Cell Transplantation With Busulfan IV
    • Calgary, Alberta, Canada
    • +3 more
    Apr 27, 2021

    Multiple Myeloma Trial in New York (busulfan, melphalan and fludarabine)

    Completed
    Has Results
    • Multiple Myeloma
    • busulfan, melphalan and fludarabine
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Nov 4, 2021

    Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Allogeneic Hematopoietic Stem Cell

    Completed
    • Acute Lymphoblastic Leukemia in Remission
    • +6 more
    • Allogeneic Bone Marrow Transplantation
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 15, 2021

    MDS, Graft Vs Host Disease, Graft-versus-host-disease Trial in Miami (Busulfan, Melphalan, Fludarabine)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Busulfan
    • +3 more
    • Miami, Florida
      Miami Cancer Institute
    Jan 10, 2023

    Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Miami (Total Body Irradiation (TBI), Thiotepa, Cyclophosphamide)

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • Leukemia, Lymphocytic, Acute
    • Total Body Irradiation (TBI)
    • +5 more
    • Miami, Florida
      Baptist Health South Florida/Miami Cancer Institute
    Nov 28, 2022

    Multiple Myeloma Trial in New York (drug, biological, procedure)

    Active, not recruiting
    • Multiple Myeloma
    • busulfan
    • +4 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 3, 2023

    Congenital Pediatric Disorders Trial in Houston (Busulfan, Cytoxan, Fludarabine)

    Active, not recruiting
    • Congenital Pediatric Disorders
    • Busulfan
    • +3 more
    • Houston, Texas
      Texas Children's Hospital
    Feb 4, 2022

    Fanconi Anemia, Severe Aplastic Anemia, MDS Trial in Minneapolis (Total Body Irradiation (TBI) (Plan 1), Cyclophosphamide (CY)

    Recruiting
    • Fanconi Anemia
    • +2 more
    • Total Body Irradiation (TBI) (Plan 1)
    • +8 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Nov 2, 2022

    Hematopoietic and Lymphoid Cell Tumor, High Risk Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome Trial in Houston

    Active, not recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +13 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +9 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 8, 2022

    Bone Marrow Disease Trial (Saliva monitoring)

    Completed
    • Bone Marrow Disease
    • Saliva monitoring
    • (no location specified)
    May 8, 2021

    CNS Lymphoma, CNS Brain Cancer, Non-Hodgkin's Lymphoma Trial in Basking Ridge, Commack, New York (Rituximab, Methotrexate,

    Active, not recruiting
    • CNS Lymphoma
    • +2 more
    • Rituximab, Methotrexate, Vincristine, Procarbazine, PBPCs collection, Busulfan, Thiotepa, and Cyclophosphamide
    • Basking Ridge, New Jersey
    • +2 more
    Jan 27, 2023

    Non Malignant Diseases, Immunodeficiencies, Hemoglobinopathies Trial in Philadelphia (RIC: Distal Campath, RIC:Intermediate

    Recruiting
    • Non Malignant Diseases
    • +2 more
    • RIC: Distal Campath
    • +2 more
    • Philadelphia, Pennsylvania
      The Children's Hospital of Philadelphia
    Mar 8, 2022

    Stem Cell Transplantation Trial in Houston (Fludarabine, Dexamethasone, Cyclophosphamide)

    Not yet recruiting
    • Stem Cell Transplantation
    • Houston, Texas
      M D Anderson Cancer Center
    May 4, 2022

    X-linked Severe Combined Immunodeficiency (XSCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

    Suspended
    • X-linked Severe Combined Immunodeficiency (XSCID)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Cutaneous T-cell Lymphoma, T-Prolymphocytic Leukemia, T-Large Granulocytic Leukemia Trial in Columbus (Romidepsin, Busulfan,

    Recruiting
    • Cutaneous T-cell Lymphoma
    • +4 more
    • Columbus, Ohio
      The Ohio State University Cancer Center
    Apr 18, 2022

    GVHD, Hematopoietic/Lymphoid Cancer Trial in Winston-Salem (fludarabine phosphate, busulfan, cyclophosphamide)

    Active, not recruiting
    • Graft Versus Host Disease
    • Hematopoietic/Lymphoid Cancer
    • fludarabine phosphate
    • +5 more
    • Winston-Salem, North Carolina
      Comprehensive Cancer Center of Wake Forest University
    Aug 5, 2022

    Hematologic Diseases, Hematologic Malignancy, Acute Lymphoblastic Leukemia Trial in Miami (device, procedure, drug)

    Withdrawn
    • Hematologic Diseases
    • +5 more
    • CliniMACS
    • +7 more
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc.
    Sep 26, 2022

    Acute Myeloid Leukemia Trial in Miami (CPX-351, Midostaurin, Busulfan)

    Recruiting
    • Acute Myeloid Leukemia
    • Miami, Florida
      Miami Cancer Institute at Baptist Health of South Florida
    Jul 27, 2022

    Target Busulfan Exposure in Children With HSCT in China

    Recruiting
    • Hematopoietic Stem Cell Transplantation
    • Busulfan
    • Suzhou, Jiangsu, China
      the First Affiliated Hospital of Soochow University
    Mar 8, 2021

    Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

    Not yet recruiting
    • Hematologic Malignancy
    • +21 more
    • (no location specified)
    Feb 9, 2023

    Myelodysplastic Syndrome, Leukemia, Acute Myeloid Leukemia Trial in Houston (Busulfan, Fludarabine)

    Completed
    Has Results
    • Myelodysplastic Syndrome
    • +2 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jan 12, 2021

    Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial (drug, radiation, procedure)

    Not yet recruiting
    • Acute Leukemia
    • +4 more
    • Busulfan
    • +8 more
    • (no location specified)
    Oct 18, 2022

    Acute Myeloid Leukemia, Advanced MDS Trial in New York (Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin,

    Completed
    Has Results
    • Acute Myeloid Leukemia
    • Advanced Myelodysplastic Syndromes
    • Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin, Stem cell transplant
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Aug 27, 2021

    Large B-cell Lymphoma Trial in Tianjin (CNCT19, Gemcitabine Injection, busulfan)

    Recruiting
    • Large B-cell Lymphoma
    • CNCT19
    • +3 more
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Jan 24, 2022

    Acute Leukemia, Immune Deficiency Disorder, Congenital Hematological Disorder Trial in Rochester (radiation, drug, procedure)

    Recruiting
    • Acute Leukemia
    • +9 more
    • Total Body Irradiation 1200 cGy
    • +7 more
    • Rochester, New York
      Wilmot Cancer Institute
    Jun 20, 2022